| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ALGN Stock Overview
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry.
Rewards
Risk Analysis
ALGN passed our risk checks.
Align Technology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$293.06 |
| 52 Week High | US$737.45 |
| 52 Week Low | US$225.86 |
| Beta | 1.78 |
| 1 Month Change | 12.06% |
| 3 Month Change | 13.53% |
| 1 Year Change | -57.32% |
| 3 Year Change | 63.10% |
| 5 Year Change | 68.27% |
| Change since IPO | 1,592.77% |
Recent News & Updates
Align Technology Non-GAAP EPS of $2.00 misses by $0.23, revenue of $969.55M misses by $16.5M
Align Technology press release (NASDAQ:ALGN): Q2 Non-GAAP EPS of $2.00 misses by $0.23. Revenue of $969.55M (-4.0% Y/Y) misses by $16.5M. Q2'22 operating income of $188.2 million and operating margin of 19.4%, which was unfavorably impacted by foreign exchange of approximately 1.1 points sequentially and approximately 2.4 points year over year. Purchased approximately 757 thousand shares of Align common stock at an average price of $264.37 per share for a total purchase price of $200.0 million. As of June 30, 2022, we had $977.2 million in cash, cash equivalents and short-term and long-term marketable securities compared to $1.1 billion as of March 31, 2022. In Q2'22, we purchased approximately 757 thousand shares of our common stock at an average price of $264.37 per share for a total purchase price of $200.0 million. Shares +0.15%.
Shareholder Returns
| ALGN | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.6% | 2.4% | 1.1% |
| 1Y | -57.3% | -21.3% | -13.0% |
Return vs Industry: ALGN underperformed the US Medical Equipment industry which returned -21.6% over the past year.
Return vs Market: ALGN underperformed the US Market which returned -12.9% over the past year.
Price Volatility
| ALGN volatility | |
|---|---|
| ALGN Average Weekly Movement | 7.5% |
| Medical Equipment Industry Average Movement | 9.8% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in US Market | 17.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ALGN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: ALGN's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 24,020 | Joe Hogan | https://www.aligntech.com |
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth.
Align Technology, Inc. Fundamentals Summary
| ALGN fundamental statistics | |
|---|---|
| Market Cap | US$23.09b |
| Earnings (TTM) | US$619.03m |
| Revenue (TTM) | US$3.99b |
37.3x
P/E Ratio5.8x
P/S RatioIs ALGN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALGN income statement (TTM) | |
|---|---|
| Revenue | US$3.99b |
| Cost of Revenue | US$1.09b |
| Gross Profit | US$2.90b |
| Other Expenses | US$2.28b |
| Earnings | US$619.03m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Oct 26, 2022
| Earnings per share (EPS) | 7.86 |
| Gross Margin | 72.60% |
| Net Profit Margin | 15.52% |
| Debt/Equity Ratio | 0% |
How did ALGN perform over the long term?
See historical performance and comparison